Modulation of human mouse double minute 2 homolog activity
US8771956B2 · kind B2 · utility
0Cited by
6References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 19, 2012 |
| Grant date | Jul 8, 2014 |
| Priority date | — |
| Expiry date | Nov 19, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/16005
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.